Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Research Agency, France | OTHER |
| SOCIETE FRANCAISE DE MEDECINE VASCULAIRE | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Arterial stiffness is associated with increased risk of cardiovascular events and death.
Most of existing technique need dedicated device for arterial stiffness evaluation and indirect calculation of intra arterial pressure. Supersonic Shear Imaging (SSI) is a novel non-invasive technique based on remote palpation of biological tissues that can image with very high temporal resolution (up to 10,000 images/s) and quantify the local viscoelastic properties of tissues. The investigators goal was to apply this SSI technique for arterial stiffness evaluation and local pulse wave velocity (PWV) calculation.
As a first step, the primary goal of this study is to establish normal values of local pulse wave velocity and arterial stiffness (carotid and femoral) by SSI on hundred healthy volunteers.
Provide a more extensive description, if desired. Avoid duplication of information to be recorded elsewhere, such as eligibility criteria or outcome measures.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Healthy volunteer | Other | Healthy volunteer undergoing two imagery evaluation :
|
|
| vEDS patients | Other | vEDS patients undergoing two imagery evaluations:
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SSI and SphygmoCor® evaluations | Other |
|
| Measure | Description | Time Frame |
|---|---|---|
| Normal Values by SSI | Normal Values by SSI of local PWV and arterial wall stiffness(carotid and femoral). | day one |
| Measure | Description | Time Frame |
|---|---|---|
| repeatability of the "primary outcome measure" | Evaluation of the repeatability of the "primary outcome measure" on 100 healthy volunteers and 30 patients with Vascular Ehlers Danlos Syndrome (vEDS). | Day one |
| Comparison between 2 populations of values by SSI |
Not provided
Inclusion criteria for Healthy Volunteers
Inclusion criteria for patient :
General Exclusion Criteria :
Exclusion criteria for Healthy volunteers
Exclusion criteria for Patients
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Emmanuel Messas, MD | Hôpital Européen Georges-Pompidou | Principal Investigator |
| Anne Blanchard, MD | Hôpital Européen Georges-Pompidou | Study Chair |
| Joseph Emmerich, MD, PhD | Hôpital Européen Georges-Pompidou | Study Chair |
| Xavier Jeunemaitre, MD, PhD | Hôpital Européen Georges-Pompidou | Study Chair |
| Michael Franck, MD | Hôpital Européen Georges-Pompidou | Study Chair |
| Olivier Steinchen, MD | Hôpital Européen Georges-Pompidou | Study Chair |
| Michel Azizi, MD, PhD | Hôpital Européen Georges-Pompidou | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CIC - Hôpital Européen Georges Pompidou | Paris | 75015 | France |
Not provided
| ID | Term |
|---|---|
| D000094623 | Ehlers-Danlos Syndrome, Type IV |
| ID | Term |
|---|---|
| D000784 | Aortic Dissection |
| D000094665 | Dissection, Blood Vessel |
| D000783 | Aneurysm |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Comparison between healthy volunteers and vEDS patients for PWV and arterial stiffness evaluated by SSI. |
| Day one |
| Comparison of values between SSI and standard gold | Concordance evaluation between PWV calculated by SSI and Aortic Pulse wave velocity calculated by ShygmoCor® | Day one |
| D002318 |
| Cardiovascular Diseases |
| D004535 | Ehlers-Danlos Syndrome |
| D020141 | Hemostatic Disorders |
| D006474 | Hemorrhagic Disorders |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D012868 | Skin Abnormalities |
| D000013 | Congenital Abnormalities |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D012873 | Skin Diseases, Genetic |
| D030342 | Genetic Diseases, Inborn |
| D003095 | Collagen Diseases |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D012871 | Skin Diseases |